• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一名急性髓系白血病患者在接受异基因造血干细胞移植后出现弥漫性皮疹。

A diffuse rash in a patient after allogeneic hematopoietic stem cell transplant for AML.

作者信息

Ferdjallah Asmaa, Boull Christina L, Stefanski Heather, Ebens Christen L

机构信息

Division of Hematology and Oncology University of Minnesota Masonic Children's Hospital Minneapolis Minnesota USA.

Division of Pediatric Dermatology University of Minnesota Masonic Children's Hospital Minneapolis Minnesota USA.

出版信息

Clin Case Rep. 2020 Sep 24;8(12):3625-3627. doi: 10.1002/ccr3.3306. eCollection 2020 Dec.

DOI:10.1002/ccr3.3306
PMID:33364009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7752433/
Abstract

Sweet's syndrome associated with relapse of leukemia suggests abnormal neutrophil response to transformation of dysfunctional leukemia blast cells, and hence, relapse should be excluded in similar clinical situation.

摘要

与白血病复发相关的Sweet综合征提示异常中性粒细胞对功能失调的白血病母细胞转化的反应，因此，在类似临床情况下应排除复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18b/7752433/efcb2112ba88/CCR3-8-3625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18b/7752433/1224643b418e/CCR3-8-3625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18b/7752433/efcb2112ba88/CCR3-8-3625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18b/7752433/1224643b418e/CCR3-8-3625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d18b/7752433/efcb2112ba88/CCR3-8-3625-g002.jpg

相似文献

1
A diffuse rash in a patient after allogeneic hematopoietic stem cell transplant for AML.一名急性髓系白血病患者在接受异基因造血干细胞移植后出现弥漫性皮疹。
Clin Case Rep. 2020 Sep 24;8(12):3625-3627. doi: 10.1002/ccr3.3306. eCollection 2020 Dec.
2
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
3
Sweet's syndrome: a revisit for hematologists and oncologists.Sweet 综合征：血液科医生和肿瘤学家的再审视。
Crit Rev Oncol Hematol. 2013 Apr;86(1):85-95. doi: 10.1016/j.critrevonc.2012.09.005. Epub 2012 Oct 7.
4
Rituximab for refractory subcutaneous Sweet's syndrome in chronic lymphocytic leukemia: A case report.利妥昔单抗治疗慢性淋巴细胞白血病难治性皮下Sweet综合征：一例报告
Mol Clin Oncol. 2016 Mar;4(3):436-440. doi: 10.3892/mco.2015.715. Epub 2015 Dec 18.
5
Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.斯威特综合征——急性发热性嗜中性皮病的全面综述
Orphanet J Rare Dis. 2007 Jul 26;2:34. doi: 10.1186/1750-1172-2-34.
6
Risk factors for post-transplant relapse and survival in younger adult patients with t(8;21)(q22;q22) acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: A multicenter retrospective study.接受异基因造血干细胞移植的t(8;21)(q22;q22)急性髓系白血病年轻成年患者移植后复发和生存的危险因素：一项多中心回顾性研究。
Front Oncol. 2023 Feb 9;13:1138853. doi: 10.3389/fonc.2023.1138853. eCollection 2023.
7
Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.组织细胞样Sweet综合征：巨噬细胞的局限性皮肤增殖，常与慢性骨髓增殖性疾病相关。
Eur J Dermatol. 2015 Jul-Aug;25(4):335-41. doi: 10.1684/ejd.2015.2586.
8
Histiocytoid Sweet's syndrome in a patient with myelodsyplastic syndrome: report and review of the literature.骨髓增生异常综合征患者的组织细胞样Sweet综合征：病例报告及文献复习
Dermatol Pract Concept. 2016 Jan 31;6(1):9-13. doi: 10.5826/dpc.0601a04. eCollection 2016 Jan.
9
[Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation].[TP53异常的骨髓增生异常综合征/急性髓系白血病患者接受异基因造血干细胞移植的生存疗效]
Zhonghua Xue Ye Xue Za Zhi. 2023 Mar 14;44(3):222-229. doi: 10.3760/cma.j.issn.0253-2727.2023.03.008.
10
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.异基因移植后复发的急性髓系白血病患者，接受高强度化疗后再行第二次异基因干细胞移植或供者淋巴细胞输注，预后得到改善。
Ann Hematol. 2021 Oct;100(10):2585-2592. doi: 10.1007/s00277-021-04616-7. Epub 2021 Jul 29.

本文引用的文献

1
Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy.对合并和未合并血液系统恶性肿瘤患者的Sweet综合征特征的见解。
Front Med (Lausanne). 2020 Feb 18;7:20. doi: 10.3389/fmed.2020.00020. eCollection 2020.
2
Insights Into the Pathogenesis of Sweet's Syndrome.Sweet 综合征发病机制的研究进展。
Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.
3
Sweet Syndrome in Pediatrics. A case report.小儿Sweet综合征。病例报告。
Rev Chil Pediatr. 2018 Aug;89(4):511-515. doi: 10.4067/S0370-41062018005000603.
4
Sweet's syndrome: diagnostic criteria revisited.Sweet 综合征：诊断标准再探。
J Dtsch Dermatol Ges. 2017 Nov;15(11):1081-1088. doi: 10.1111/ddg.13350. Epub 2017 Oct 5.
5
Sweet Syndrome: A Review and Update.Sweet综合征：综述与更新
Actas Dermosifiliogr. 2016 Jun;107(5):369-78. doi: 10.1016/j.ad.2015.12.001. Epub 2016 Jan 27.
6
Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.斯威特综合征——急性发热性嗜中性皮病的全面综述
Orphanet J Rare Dis. 2007 Jul 26;2:34. doi: 10.1186/1750-1172-2-34.
7
Cutaneous manifestations of myelogenous leukemia.骨髓性白血病的皮肤表现。
AMA Arch Derm. 1955 May;71(5):605-14. doi: 10.1001/archderm.1955.01540290045009.
8
AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS.急性发热性嗜中性皮病
Br J Dermatol. 1964 Aug-Sep;76:349-56. doi: 10.1111/j.1365-2133.1964.tb14541.x.
9
Sweet's syndrome: systemic signs and symptoms and associated disorders.斯威特综合征：全身症状体征及相关疾病
Mayo Clin Proc. 1995 Mar;70(3):234-40. doi: 10.4065/70.3.234.